BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38506227)

  • 1. Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle.
    Khaled YS; Khot MI; Aiyappa-Maudsley R; Maisey T; Pramanik A; Tiernan J; Lintern N; Al-Enezi E; Shamsuddin SH; Tomlinson D; Coletta L; Millner PA; Hughes TA; Jayne DG
    Nanoscale; 2024 Apr; 16(14):7185-7199. PubMed ID: 38506227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent imaging using novel conjugated polymeric nanoparticles-affimer probes in complex
    Jolugbo P; Willott T; Lin WH; Maisey T; O'Callaghan D; Green MA; Jayne DG; Khot MI
    Nanoscale; 2023 Aug; 15(30):12476-12480. PubMed ID: 37466243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affimer Tagged Cubosomes: Targeting of Carcinoembryonic Antigen Expressing Colorectal Cancer Cells Using
    Pramanik A; Xu Z; Shamsuddin SH; Khaled YS; Ingram N; Maisey T; Tomlinson D; Coletta PL; Jayne D; Hughes TA; Tyler AII; Millner PA
    ACS Appl Mater Interfaces; 2022 Mar; 14(9):11078-11091. PubMed ID: 35196008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer.
    da Paz MC; Santos Mde F; Santos CM; da Silva SW; de Souza LB; Lima EC; Silva RC; Lucci CM; Morais PC; Azevedo RB; Lacava ZG
    Int J Nanomedicine; 2012; 7():5271-82. PubMed ID: 23055733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CEA-targeted nanoparticles allow specific in vivo fluorescent imaging of colorectal cancer models.
    Tiernan JP; Ingram N; Marston G; Perry SL; Rushworth JV; Coletta PL; Millner PA; Jayne DG; Hughes TA
    Nanomedicine (Lond); 2015; 10(8):1223-31. PubMed ID: 25694062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
    Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM
    J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models.
    Elekonawo FMK; Bos DL; Goldenberg DM; Boerman OC; Rijpkema M
    EJNMMI Res; 2019 Dec; 9(1):108. PubMed ID: 31828541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside.
    Li L; Lin X; Wang L; Ma X; Zeng Z; Liu F; Jia B; Zhu H; Wu A; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3735-3749. PubMed ID: 37382662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells.
    Pereira I; Sousa F; Kennedy P; Sarmento B
    Int J Pharm; 2018 Oct; 549(1-2):397-403. PubMed ID: 30110619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen regulation in human colorectal tumor cells by a site-selective cyclic AMP analogue: a comparison with interferon-gamma.
    Guadagni F; Tortora G; Roselli M; Clair T; Cho-Chung YS; Schlom J; Greiner JW
    Int J Cancer; 1991 May; 48(3):413-22. PubMed ID: 1645700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-gamma.
    Guadagni F; Witt PL; Robbins PF; Schlom J; Greiner JW
    Cancer Res; 1990 Oct; 50(19):6248-55. PubMed ID: 2119252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models.
    Meier D; Botter SM; Campanile C; Robl B; Gräfe S; Pellegrini G; Born W; Fuchs B
    Int J Cancer; 2017 Apr; 140(7):1680-1692. PubMed ID: 27943293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer targeting with biomolecules: a comparative study of photodynamic therapy efficacy using antibody or lectin conjugated phthalocyanine-PEG gold nanoparticles.
    Obaid G; Chambrier I; Cook MJ; Russell DA
    Photochem Photobiol Sci; 2015 Apr; 14(4):737-47. PubMed ID: 25604735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target mediated disposition of T84.66, a monoclonal anti-CEA antibody: application in the detection of colorectal cancer xenografts.
    Urva SR; Balthasar JP
    MAbs; 2010; 2(1):67-72. PubMed ID: 20081377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer.
    Lee JH; Lee SW
    Mol Biol Rep; 2019 Aug; 46(4):3835-3842. PubMed ID: 31028570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Foslip® mediated photodynamic therapy on 5-fluorouracil resistant human colorectal cancer cells.
    Wu R; Yow C; Law E; Chu E; Huang Z
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101945. PubMed ID: 32768589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific adhesion of carcinoembryonic antigen-bearing colorectal cancer cells to immobilized carcinoembryonic antigen.
    Levin LV; Griffin TW
    Cancer Lett; 1991 Nov; 60(2):143-52. PubMed ID: 1657369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Catch-and-Release" Anti-Carcinoembryonic Antigen Monoclonal Antibody Leads to Greater Plasma and Tumor Exposure in a Mouse Model of Colorectal Cancer.
    Engler FA; Polli JR; Li T; An B; Otteneder M; Qu J; Balthasar JP
    J Pharmacol Exp Ther; 2018 Jul; 366(1):205-219. PubMed ID: 29735609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetuximab-Ag
    Hashemkhani M; Demirci G; Bayir A; Muti A; Sennaroglu A; Mohammad Hadi L; Yaghini E; Loizidou M; MacRobert AJ; Yagci Acar H
    Nanoscale; 2021 Sep; 13(35):14879-14899. PubMed ID: 34533177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells.
    Shiozawa M; Chang CH; Huang YC; Chen YC; Chi MS; Hao HC; Chang YC; Takeda S; Chi KH; Wang YS
    BMC Immunol; 2018 Aug; 19(1):27. PubMed ID: 30075754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.